Shortage of Provera (medroxyprogesterone acetate) 100mg tablets

Pfizer, the sole supplier of Provera tablets, are experiencing manufacturing delays, and are out of stock of the 100mg tablets until week ending 8th November 2019 and there are insufficient amounts of other strengths to bridge the gap in supply.  At present it seems possible to import supplies of unlicensed medroxyprogesterone acetate 100mg tablets.

This memo advises on alternative treatment options should imports not be available.

CancersCyproteroneMedroxyprogesteroneMegestrolNewsShortages and discontinuations

Attachments